Related Experiment Video
Updated: May 16, 2025

07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
6.4K
Cannabis-induced Catatonia: A Case Study.
Darby Herkert1, Matthew Majeske
1Department of Psychiatry, Mount Sinai Morningside-West, New York, NY.
Journal of Psychiatric Practice
|March 31, 2025
Summary
Catatonia, a condition of abnormal movements and behavior, can be linked to cannabis use. This case report highlights a young adult male who developed catatonia solely from marijuana use, emphasizing the need for more research.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Case Study
Background:
- Catatonia is a neuropsychiatric syndrome characterized by motor, behavioral, and cognitive abnormalities.
- It is often associated with mood disorders and schizophrenia but can occur in other contexts.
- Recent research suggests potential links between cannabis use and neuropsychiatric effects.
Purpose of the Study:
- To report a case of catatonia in a young adult male with no other predisposing factors.
- To contribute to the understanding of cannabis-associated catatonia.
- To underscore the need for increased awareness and research into marijuana's neuropsychiatric impact.
Main Methods:
- Case report of a young adult male patient.
- Clinical observation and assessment of symptoms.
- Review of patient history for predisposing factors.
Main Results:
- The patient presented with catatonia.
- No other contributing factors for catatonia were identified besides cannabis use.
- This case supports a correlation between cannabis consumption and the onset of catatonia.
Conclusions:
- Cannabis use may be a direct cause of catatonia in some individuals.
- Further research is crucial to elucidate the mechanisms of cannabis-associated catatonia.
- Enhanced patient counseling regarding marijuana's potential neuropsychiatric risks is warranted.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
142
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
142
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
192
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
192

